Baird Reiterates Bullish Stance on Solazyme (SZYM) on Raise and Product Announcement
Tweet Send to a Friend
Baird analyst Ben Kallo reiterated an Outperform rating and $18 price target on Solazyme (NASDAQ: SZYM) amid what they calling ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
